SMi Source lesson Multiple Sclerosis: Treatments and Strategies has the following microlearning topics
1. MS Therapies
2. Learning Objectives
3. Currently Approved Therapies: Interferon Beta (IFN beta)
4. Betaseron/Extavia
5. Avonex
6. Rebif
7. Knowledge Check: Currently Approved Therapies: Interferon Beta
8. Knowledge Check: Intramuscular Injection of Interferon Beta
9. Tysabri
10. Currently Approved Therapies: Tysabri
11. Pivotal Trials
12. Knowledge Check: Currently Approved Therapies: Tysabri
13. Knowledge Check: Leukoencephalopathy
14. Gilenya
15. Pivotal Trials: Gilenya
16. FREEDOMS II
17. Knowledge Check: TRANSFORMS Trial
18. Knowledge Check: Currently Approved Therapies: Gilenya
19. Novantrone, Mitoxantrone
20. Knowledge Check: Currently Approved Therapies: Novantrone
21. Aubagio
22. Pivotal Trials
23. Knowledge Check: TEMSO Study
24. Knowledge Check: TOWER Study
25. Tecfidera
26. Pivotal Trials CONFIRM (Study 2 in PI)
27. Tecfidera Safety (as compiled for PI)
28. Knowledge Check: CONFIRM Study Dose Schedule
29. Knowledge Check: Tecfidera Adverse Reactions
30. Proposed Mechanism of Action Summary
31. Efficacy of Approved Multiple Sclerosis Therapies
32. Knowledge Check: Summary of Approved Therapies
33. Emerging Therapies
34. Emerging Therapies Overview
35. Emerging Therapies: Alemtuzumab
36. Emerging Therapies: Ocrelizumab
37. Emerging Therapies: Peginterferon beta-1a
38. NU100
39. Knowledge Check: Emerging Therapies
Lesson Multiple Sclerosis: Treatments and Strategies teaches these concepts
MS Therapies
Lesson Multiple Sclerosis: Treatments and Strategies addresses these key points
MS Therapies
FDA Approved Therapies for MS
Lesson Multiple Sclerosis: Treatments and Strategies is built from these main references. Log into SMi Source for a complete list and details.
Reardon J and Perumal JS. Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis. Drug Design, Development, and Therapy. 2013; 7:1187-1193.